Patients With Suspected Prostate Cancer Clinical Trial
— HEMThe aim of our study is to determine if the levels of the "HEM" substance in seminal plasma are associated with the presence of prostate cancer in transrectal prostate biopsy.
Status | Not yet recruiting |
Enrollment | 28 |
Est. completion date | |
Est. primary completion date | April 2013 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 45 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Clinical or laboratory suspected of prostate cancer Exclusion Criteria: - Inability to ejaculate |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitario Parc Taulí | Sabadell | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Corporacion Parc Tauli |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | substance "HEM" concentration in seminal plasma (mEq/L measured by spectro-photometry | 1 hour | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05763355 -
Multicentric Comparative Prospective Study of the Benefits and Risks of Biopsy Prostate Using Transrectal or Transperineal Procedure for the Prostate Cancer Diagnostic
|
N/A |